Gilead Sciences (GILD) Debt/Assets Ratio: History & Chart

Gilead Sciences, Inc.(GILD)

Drug Manufacturers - General · Foster City, CA

$145.97-5.03 (-3.33%)

Delayed quote: Sep 8, 2026, 1:05 PM EDT

About Gilead Sciences, Inc.

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.

Foster City, CA

17,000 employees

www.gilead.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Daniel O'Day

View full financials

GILD Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

53.17%

DEBT TO ASSETS RATIO AVG TTM

44.44%

DEBT TO ASSETS RATIO AVG 3Y

42.70%

DEBT TO ASSETS RATIO AVG 5Y

42.08%

DEBT TO ASSETS RATIO AVG 10Y

43.09%

DEBT TO ASSETS RATIO AVG 15Y

42.76%

DEBT TO ASSETS RATIO AVG 20Y

36.80%

CURRENT VS TTM AVG

+19.65%

CURRENT VS 3Y AVG

+24.53%

CURRENT VS 5Y AVG

+26.35%

CURRENT VS 10Y AVG

+23.39%

CURRENT VS 15Y AVG

+24.34%

CURRENT VS 20Y AVG

+44.49%

SECTOR MEDIAN · HEALTHCARE

0.28%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+18889.45%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Gilead Sciences, Inc. (GILD)	$181.23B	53.17%	44.44%	42.70%	42.08%
Abbott Laboratories (ABT)vs ›	$183.57B	0.30%	N/A	N/A	N/A
Novo Nordisk A/S (NVO)vs ›	$201.31B	0.24%	N/A	N/A	N/A
Pfizer Inc. (PFE)vs ›	$159.16B	0.31%	N/A	N/A	N/A
Amgen Inc. (AMGN)vs ›	$212.94B	0.60%	N/A	N/A	N/A
Danaher Corporation (DHR)vs ›	$144.91B	0.29%	N/A	N/A	N/A
Thermo Fisher Scientific Inc. (TMO)vs ›	$225.31B	0.38%	N/A	N/A	N/A
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$133.93B	0.07%	N/A	N/A	N/A
Bristol-Myers Squibb Company (BMY)vs ›	$132.86B	0.49%	N/A	N/A	N/A
Intuitive Surgical, Inc. (ISRG)vs ›	$123.70B	0.00%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Gilead Sciences, Inc. (GILD)

$181.23B

53.17%

44.44%

42.70%

42.08%

Abbott Laboratories (ABT)vs ›

$183.57B

0.30%

N/A

Novo Nordisk A/S (NVO)vs ›

$201.31B

0.24%

N/A

Pfizer Inc. (PFE)vs ›

$159.16B

0.31%

N/A

Amgen Inc. (AMGN)vs ›

$212.94B

0.60%

N/A

Danaher Corporation (DHR)vs ›

$144.91B

0.29%

N/A

Thermo Fisher Scientific Inc. (TMO)vs ›

$225.31B

0.38%

N/A

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$133.93B

0.07%

N/A

Bristol-Myers Squibb Company (BMY)vs ›

$132.86B

0.49%

N/A

Intuitive Surgical, Inc. (ISRG)vs ›

$123.70B

0.00%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Gilead Sciences, Inc. (GILD)?

The debt to assets ratio for GILD stock is 53.17%.

Is Gilead Sciences, Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 53.17% is 26% above its 5-year average of 42.08%, near the high end of its 5-year range (39.29%–53.17%).

What is the TTM average debt to assets ratio for Gilead Sciences, Inc. (GILD)?

The TTM average debt to assets ratio for GILD stock is 44.44%.

What is the 3Y average debt to assets ratio for Gilead Sciences, Inc. (GILD)?

The 3Y average debt to assets ratio for GILD stock is 42.70%.

What is the 5Y average debt to assets ratio for Gilead Sciences, Inc. (GILD)?

The 5Y average debt to assets ratio for GILD stock is 42.08%.

What is the 10Y average debt to assets ratio for Gilead Sciences, Inc. (GILD)?

The 10Y average debt to assets ratio for GILD stock is 43.09%.

What is the 15Y average debt to assets ratio for Gilead Sciences, Inc. (GILD)?

The 15Y average debt to assets ratio for GILD stock is 42.76%.

What is the 20Y average debt to assets ratio for Gilead Sciences, Inc. (GILD)?

The 20Y average debt to assets ratio for GILD stock is 36.80%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	53.17%
2026-03-31	39.40%
2025-12-31	42.25%
2025-09-30	42.61%
2025-06-30	44.77%
2025-03-31	44.21%
2024-12-31	46.31%
2024-09-30	42.64%
2024-06-30	43.58%
2024-03-31	44.76%
2023-12-31	41.30%
2023-09-30	40.05%
2023-06-30	40.50%
2023-03-31	40.79%
2022-12-31	39.94%
2022-09-30	40.32%
2022-06-30	41.70%
2022-03-31	41.55%
2021-12-31	39.29%
2021-09-30	41.26%
2021-06-30	44.39%
2021-03-31	44.70%
2020-12-31	45.90%
2020-09-30	48.11%
2020-06-30	43.09%
2020-03-31	40.34%
2019-12-31	39.91%
2019-09-30	41.57%
2019-06-30	41.26%
2019-03-31	42.30%
2018-12-31	42.91%
2018-09-30	42.48%
2018-06-30	44.46%
2018-03-31	44.44%
2017-12-31	47.72%
2017-09-30	45.25%
2017-06-30	43.64%
2017-03-31	45.62%
2016-12-31	46.24%
2016-09-30	47.82%
2016-06-30	44.27%
2016-03-31	47.78%
2015-12-31	42.65%
2015-09-30	43.89%
2015-06-30	31.34%
2015-03-31	32.26%
2014-12-31	35.78%
2014-09-30	32.62%
2014-06-30	30.46%
2014-03-31	34.92%
2013-12-31	29.39%
2013-09-30	32.55%
2013-06-30	32.43%
2013-03-31	36.01%
2012-12-31	38.72%
2012-09-30	41.84%
2012-06-30	44.38%
2012-03-31	47.26%
2011-12-31	43.96%
2011-09-30	30.80%
2011-06-30	30.55%
2011-03-31	34.67%
2010-12-31	30.06%
2010-09-30	30.13%
2010-06-30	16.70%
2010-03-31	11.63%
2009-12-31	12.93%
2009-09-30	15.82%
2009-06-30	19.05%
2009-03-31	15.61%
2008-12-31	16.73%
2008-09-30	19.03%
2008-06-30	20.41%
2008-03-31	22.29%
2007-12-31	22.48%
2007-09-30	26.69%
2007-06-30	29.17%
2007-03-31	30.25%
2006-12-31	34.52%
2006-09-30	27.18%
2006-06-30	28.95%
2006-03-31	6.06%
2005-12-31	7.99%
2005-09-30	0.01%
2005-06-30	0.02%
2005-03-31	0.02%
2004-12-31	0.02%
2004-09-30	17.39%
2004-06-30	19.09%
2004-03-31	20.61%
2003-12-31	22.22%
2003-09-30	50.98%
2003-06-30	55.39%
2003-03-31	63.13%
2002-12-31	46.23%
2002-09-30	28.56%

DATE

DEBT TO ASSETS RATIO

2026-06-30

53.17%

2026-03-31

39.40%

2025-12-31

42.25%

2025-09-30

42.61%

2025-06-30

44.77%

2025-03-31

44.21%

2024-12-31

46.31%

2024-09-30

42.64%

2024-06-30

43.58%

2024-03-31

44.76%

2023-12-31

41.30%

2023-09-30

40.05%

2023-06-30

40.50%

2023-03-31

40.79%

2022-12-31

39.94%

2022-09-30

40.32%

2022-06-30

41.70%

2022-03-31

41.55%

2021-12-31

39.29%

2021-09-30

41.26%

2021-06-30

44.39%

2021-03-31

44.70%

2020-12-31

45.90%

2020-09-30

48.11%

2020-06-30

43.09%

2020-03-31

40.34%

2019-12-31

39.91%

2019-09-30

41.57%

2019-06-30

41.26%

2019-03-31

42.30%

2018-12-31

42.91%

2018-09-30

42.48%

2018-06-30

44.46%

2018-03-31

44.44%

2017-12-31

47.72%

2017-09-30

45.25%

2017-06-30

43.64%

2017-03-31

45.62%

2016-12-31

46.24%

2016-09-30

47.82%

2016-06-30

44.27%

2016-03-31

47.78%

2015-12-31

42.65%

2015-09-30

43.89%

2015-06-30

31.34%

2015-03-31

32.26%

2014-12-31

35.78%

2014-09-30

32.62%

2014-06-30

30.46%

2014-03-31

34.92%

2013-12-31

29.39%

2013-09-30

32.55%

2013-06-30

32.43%

2013-03-31

36.01%

2012-12-31

38.72%

2012-09-30

41.84%

2012-06-30

44.38%

2012-03-31

47.26%

2011-12-31

43.96%

2011-09-30

30.80%

2011-06-30

30.55%

2011-03-31

34.67%

2010-12-31

30.06%

2010-09-30

30.13%

2010-06-30

16.70%

2010-03-31

11.63%

2009-12-31

12.93%

2009-09-30

15.82%

2009-06-30

19.05%

2009-03-31

15.61%

2008-12-31

16.73%

2008-09-30

19.03%

2008-06-30

20.41%

2008-03-31

22.29%

2007-12-31

22.48%

2007-09-30

26.69%

2007-06-30

29.17%

2007-03-31

30.25%

2006-12-31

34.52%

2006-09-30

27.18%

2006-06-30

28.95%

2006-03-31

6.06%

2005-12-31

7.99%

2005-09-30

0.01%

2005-06-30

0.02%

2005-03-31

0.02%

2004-12-31

0.02%

2004-09-30

17.39%

2004-06-30

19.09%

2004-03-31

20.61%

2003-12-31

22.22%

2003-09-30

50.98%

2003-06-30

55.39%

2003-03-31

63.13%

2002-12-31

46.23%

2002-09-30

28.56%

Debt to Assets Ratio: 53.17%

GILD Debt to Assets Ratio

GILD Average Debt to Assets Ratio Chart

GILD Current vs Average Debt to Assets Ratio Chart

GILD Debt to Assets Ratio Metrics

GILD Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

GILD Debt to Assets Ratio History

Related Metrics